Posted on 9 月 27, 20249/27/24
Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024
Posted on 9 月 5, 20249/5/24
The Promise of a Direct-to-Patient Model – Breaking Down What’s Really Needed for Better Patient Access
Posted on 9 月 3, 20249/3/24
The Future of Global Commercialization: Unified, Data-Driven and Patient-Centric
Posted on 8 月 13, 20248/13/24
IDN Trends, Insights and Strategies Every Manufacturer Should Know
Posted on 8 月 5, 20248/5/24
Understanding IDNs and What They Mean to the Pharmaceutical Industry–Q&A with Greg Skalicky
Posted on 7 月 22, 20247/22/24
PDURS Explained: The FDA’s New Framework for Adding Software to Drug Labels
Posted on 7 月 17, 20247/17/24
In-Depth with an Industry Leader: Global Launch Ambitions and Paradigm Shifts
Posted on 7 月 16, 20247/16/24
Maximizing Medical Affairs and MSL Impact: How Choosing a Strategic Launch Partner Propels Success
Posted on 7 月 8, 20247/8/24
Report: Integrated Delivery Network Trends and Engagement Strategies Every Drug Manufacturer Needs to Know
Posted on 6 月 28, 20246/28/24